| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $4.96 ▼ -0.69% | Yesterday | $5.00 ▲ +0.29% | Tomorrow's Atara Biotherapeutics Inc. Common Stock (ATRA) setup is anchored to $4.99 and targets $4.96 (-0.69%). The near-term read is downside; watch $5.14 / $4.84 because daily realized volatility is about 3.57%. |
Tomorrow's Atara Biotherapeutics Inc. Common Stock (ATRA) setup is anchored to $4.99 and targets $4.96 (-0.69%). The near-term read is downside; watch $5.14 / $4.84 because daily realized volatility is about 3.57%. | ||||
| Week | $4.88 ▼ -2.16% | Last Week | $5.04 ▲ +0.91% | The 7-day Atara Biotherapeutics Inc. Common Stock model moves from $5.04 to $4.88 (-2.16%). It gives downside momentum context for this stock, so breaks around $5.14 / $4.84 matter more than a single tick. |
The 7-day Atara Biotherapeutics Inc. Common Stock model moves from $5.04 to $4.88 (-2.16%). It gives downside momentum context for this stock, so breaks around $5.14 / $4.84 matter more than a single tick. | ||||
| Month | $4.76 ▼ -4.59% | Last Month | $5.09 ▲ +1.93% | The 1-month Atara Biotherapeutics Inc. Common Stock target is $4.76 (-4.59%), compared with the live reference near $4.99. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Atara Biotherapeutics Inc. Common Stock target is $4.76 (-4.59%), compared with the live reference near $4.99. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $4.58 ▼ -8.24% | Last Year | $5.16 ▲ +3.46% | The 1-year Atara Biotherapeutics Inc. Common Stock scenario points to $4.58 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Atara Biotherapeutics Inc. Common Stock scenario points to $4.58 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $4.15 ▼ -16.80% | 5 Years Ago | $5.34 ▲ +7.06% | The 5-year Atara Biotherapeutics Inc. Common Stock view is $4.15 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Atara Biotherapeutics Inc. Common Stock view is $4.15 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $4.99 | Mid |
| Daily Change | 0.00% | Mid |
| Volatility Cap | 20.0% | Mid |
| Confidence | 57% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $4.99 | Daily Change | 0.00% |
| Market Cap | $40.81M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.